Anteris Technologies Global Operating Income 2024-2025 | AVR

Anteris Technologies Global operating income from 2024 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Anteris Technologies Global Operating Income 2024-2025 | AVR

Anteris Technologies Global operating income from 2024 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$184.9B
Intuitive Surgical (ISRG)$169.9B
IDEXX Laboratories (IDXX)$51.8B
Edwards Lifesciences (EW)$47.7B
Alcon (ALC)$39.2B
IQVIA Holdings (IQV)$32.1B
DexCom (DXCM)$29.4B
Mettler-Toledo (MTD)$26.4B
STERIS (STE)$24.1B
Waters (WAT)$17.7B
SONOVA HOLDING (SONVY)$17.2B
Hologic (HOLX)$14.8B
Penumbra (PEN)$10.6B
Globus Medical (GMED)$8.3B
Sysmex ADR (SSMXY)$8.1B
Masimo (MASI)$7.7B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.5B
TransMedics (TMDX)$4B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3B
Alphatec Holdings (ATEC)$2.4B
Veracyte (VCYT)$2.4B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.2B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B